Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             82 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study Okura, Tsuyoshi
2018
9 3 p. 1143-1147
artikel
2 A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study Okura, Tsuyoshi

9 3 p. 1143-1147
artikel
3 Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes Perez-Nieves, Magaly
2018
9 3 p. 1099-1111
artikel
4 Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes Perez-Nieves, Magaly

9 3 p. 1099-1111
artikel
5 A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes Webb, Neil
2018
9 3 p. 973-986
artikel
6 A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes Webb, Neil

9 3 p. 973-986
artikel
7 A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs Yi, Yingping
2018
9 3 p. 1073-1082
artikel
8 A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs Yi, Yingping

9 3 p. 1073-1082
artikel
9 A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus Candido, Riccardo
2018
9 3 p. 927-949
artikel
10 A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus Candido, Riccardo

9 3 p. 927-949
artikel
11 Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Dai, Xia
2018
9 3 p. 1269-1277
artikel
12 Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Dai, Xia

9 3 p. 1269-1277
artikel
13 A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin Witkowski, Michal
2018
9 3 p. 1233-1251
artikel
14 A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin Witkowski, Michal

9 3 p. 1233-1251
artikel
15 A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Anti-Diabetic Drugs Witkowski, Michal
2018
9 3 p. 1149-1167
artikel
16 A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Anti-Diabetic Drugs Witkowski, Michal

9 3 p. 1149-1167
artikel
17 Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study Ciresi, Alessandro
2018
9 3 p. 1413
artikel
18 Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study Ciresi, Alessandro

9 3 p. 1413
artikel
19 Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study Okajima, Fumitaka
2018
9 3 p. 1049-1059
artikel
20 Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study Okajima, Fumitaka

9 3 p. 1049-1059
artikel
21 Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review Meece, Jerry
2018
9 3 p. 877-890
artikel
22 Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review Meece, Jerry

9 3 p. 877-890
artikel
23 Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Wang, Qiang
2018
9 3 p. 1335-1345
artikel
24 Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Wang, Qiang

9 3 p. 1335-1345
artikel
25 Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis Suzuki, Shuichi
2018
9 3 p. 1125-1141
artikel
26 Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis Suzuki, Shuichi

9 3 p. 1125-1141
artikel
27 Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis Jiang, Ruixuan
2018
9 3 p. 1021-1036
artikel
28 Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis Jiang, Ruixuan

9 3 p. 1021-1036
artikel
29 Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk Goncalves, Edison
2018
9 3 p. 919-926
artikel
30 Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk Goncalves, Edison

9 3 p. 919-926
artikel
31 Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial Yin, Ting-Ting
2018
9 3 p. 1253-1267
artikel
32 Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial Yin, Ting-Ting

9 3 p. 1253-1267
artikel
33 Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia Lalić, Nebojša
2018
9 3 p. 1201-1216
artikel
34 Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia Lalić, Nebojša

9 3 p. 1201-1216
artikel
35 Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States Wilkinson, Lars
2018
9 3 p. 951-961
artikel
36 Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States Wilkinson, Lars

9 3 p. 951-961
artikel
37 DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK Pollock, Richard F.
2018
9 3 p. 1217-1232
artikel
38 DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK Pollock, Richard F.

9 3 p. 1217-1232
artikel
39 Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study Ramos, Analía
2018
9 3 p. 1359-1367
artikel
40 Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study Ramos, Analía

9 3 p. 1359-1367
artikel
41 Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol Hinton, William
2018
9 3 p. 1397-1402
artikel
42 Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol Hinton, William

9 3 p. 1397-1402
artikel
43 Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Chen, Wei
2018
9 3 p. 1113-1124
artikel
44 Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Chen, Wei

9 3 p. 1113-1124
artikel
45 Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies Ginsberg, Henry N.
2018
9 3 p. 1317-1334
artikel
46 Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies Ginsberg, Henry N.

9 3 p. 1317-1334
artikel
47 Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis Nørgaard, Kirsten
2018
9 3 p. 891-917
artikel
48 Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis Nørgaard, Kirsten

9 3 p. 891-917
artikel
49 Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey Murayama, Hiroki
2018
9 3 p. 1185-1199
artikel
50 Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey Murayama, Hiroki

9 3 p. 1185-1199
artikel
51 Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis Huang, Feng
2018
9 3 p. 1061-1072
artikel
52 Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis Huang, Feng

9 3 p. 1061-1072
artikel
53 Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a “Chicken and Egg” Paradigm in Ketosis-Prone Diabetes Song, Runbo
2018
9 3 p. 1377-1383
artikel
54 Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a “Chicken and Egg” Paradigm in Ketosis-Prone Diabetes Song, Runbo

9 3 p. 1377-1383
artikel
55 Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report Takeshima, Ken
2018
9 3 p. 1385-1395
artikel
56 Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report Takeshima, Ken

9 3 p. 1385-1395
artikel
57 Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis Uloko, Andrew E.
2018
9 3 p. 1307-1316
artikel
58 Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis Uloko, Andrew E.

9 3 p. 1307-1316
artikel
59 Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA Blonde, Lawrence
2018
9 3 p. 1347-1358
artikel
60 Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA Blonde, Lawrence

9 3 p. 1347-1358
artikel
61 Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years Li, Qian
2018
9 3 p. 1279-1293
artikel
62 Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years Li, Qian

9 3 p. 1279-1293
artikel
63 Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial Su, Qing
2018
9 3 p. 987-999
artikel
64 Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial Su, Qing

9 3 p. 987-999
artikel
65 Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Ishii, Hitoshi
2018
9 3 p. 1001-1019
artikel
66 Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Ishii, Hitoshi

9 3 p. 1001-1019
artikel
67 Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus Bruinstroop, Eveline
2018
9 3 p. 1369-1375
artikel
68 Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus Bruinstroop, Eveline

9 3 p. 1369-1375
artikel
69 Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance Haneda, Masakazu
2018
9 3 p. 1083-1097
artikel
70 Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance Haneda, Masakazu

9 3 p. 1083-1097
artikel
71 Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial Mita, Tomoya
2018
9 3 p. 1403-1412
artikel
72 Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial Mita, Tomoya

9 3 p. 1403-1412
artikel
73 The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System Parekh, Witesh
2018
9 3 p. 1037-1047
artikel
74 The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System Parekh, Witesh

9 3 p. 1037-1047
artikel
75 The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study Hu, Yanjin
2018
9 3 p. 1295-1305
artikel
76 The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study Hu, Yanjin

9 3 p. 1295-1305
artikel
77 The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis Mu, Pan-wei
2018
9 3 p. 963-971
artikel
78 The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis Mu, Pan-wei

9 3 p. 963-971
artikel
79 Thoughts, Words, Action: The Alma-Ata Declaration to Diabetes Care Transformation Kalra, Sanjay
2018
9 3 p. 873-876
artikel
80 Thoughts, Words, Action: The Alma-Ata Declaration to Diabetes Care Transformation Kalra, Sanjay

9 3 p. 873-876
artikel
81 Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin Blonde, Lawrence
2018
9 3 p. 1169-1184
artikel
82 Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin Blonde, Lawrence

9 3 p. 1169-1184
artikel
                             82 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland